DRP.ID

Welcome to the Brand page for “DRP.ID”, which is offered here for Educational services, providing educational programs about neurodegenerative diseases and disorders and dementia and diagnosis, identification, management, treatment, and patient support options for these conditions; multimedia educational services in the nature of recording and production services in the fields of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management; providing on-line newsletters in the field of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management;electronic publications in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment;publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment; questionnaires on medical issues;drp.id dementia-related psychosis identification;promoting awareness of patient support offerings for neurodegenerative diseases and disorders and dementia; medical referrals;medical consulting with respect to neurodegenerative diseases and disorders and dementia, including dementia-related psychosis and their identification and treatment; providing online information for health care providers and patients in the field of neurodegenerative diseases and disorders and dementia; medical informational support services, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients and healthcare professionals all related to neurodegenerative diseases and disorders and dementia;testing, inspection, research, and development of diagnostic tests and questionnaires for symptoms of dementia-related psychosis, including hallucinations and delusions associated with dementia-related psychosis;.

Its status is currently believed to be active. Its class is unavailable. “DRP.ID” is believed to be currently owned by “ACADIA Pharmaceuticals, Inc.”